Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05230511 · ClinicalTrials.gov registry record · Phase 2
Intravesical LGG VS Saline Bladder Wash RCT
A Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05230511: Recruiting Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder, sponsored by Medstar Health Research Institute.
NCT05230511 is a Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 120 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05230511, a Phase 2 study of Spinal Cord Injuries and Neurogenic Bladder, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This is the first ever comparative effectiveness study of an antibiotic-sparing novel self-management intervention to prevent complicated urinary tract infection (UTI).
Primary Outcome
A tool that describes urinary tract impairment, awareness of need to empty bladder, main bladder emptying method, medications used for bladder management, surgeries, and change in urinary symptoms in the past year. Score is not associated with outcome.
Conditions Studied
Interventions
- DRUG Lactobacillus RhamnosusGG
- DRUG Saline bladder wash
Study Locations (1)
District of Columbia
- MedStar National Rehabilitation Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
What NCT05230511 shows while recruiting
NCT05230511 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (97% higher).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Lactobacillus RhamnosusGG is the first listed.
NCT05230511 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05230511 about?
NCT05230511 is a clinical study titled "Intravesical LGG VS Saline Bladder Wash RCT". This is the first ever comparative effectiveness study of an antibiotic-sparing novel self-management intervention to prevent complicated urinary tract infection (UTI).
What is the current status of trial NCT05230511?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2022-06-13. Estimated completion is 2026-12-31.
What conditions does trial NCT05230511 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Neurogenic Bladder.
What interventions are being tested in trial NCT05230511?
The interventions under investigation include: Lactobacillus RhamnosusGG (DRUG), Saline bladder wash (DRUG).
Who is sponsoring clinical trial NCT05230511?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05230511 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05230511's enrollment target sits among peer trials
120 25th of 202 higher than 176 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Epidural Stimulation and Resistance Training After SCI
RECRUITING · Phase 2
-
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
Effects of 5HTP on the Injured Human Spinal Cord
RECRUITING · Phase 2
-
Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy